Knife River: A Transitional Year at a Trough Multiple
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets production, pricing and AI-led efficiency gains in 2027.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets production, pricing and AI-led efficiency gains in 2027.
Love a good GTA VI tailwind $EVC
The good ol' bird flu bull thesis dropped yesterday $CALM
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
Qualstar targets 8% revenue growth in 2027 and 12% in 2028 as AI-driven storage demand and LTO-10 replacement cycles revive tape libraries.
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Euroseas’ feeder-vessel renewals and contracted cash flow support higher 2027 earnings, while Red Sea normalization, vessel values and…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…
BLND · long Blend Labs (BLND) is presented as a long investment idea, with prior VIC writeups cited for business background.
Star Equity’s $5 per-share Harte-Hanks acquisition offers $2.50 cash plus 0.25 STRRP per share after proration, against a $2 break price.
AVITA Medical’s more predictable reimbursement, RECELL GO rollout and PermeaDerm economics support adoption, with cash flow breakeven…
Portillo’s reset follows weak Texas unit economics, cutting next year’s openings to five from roughly 10 annually and shrinking store…
Planet Fitness runs 2,930 clubs and 21.5 million memberships through an asset-light franchise model funded by $15 monthly dues, royalties…
Warrior Met Coal’s lower-cost longwall mines and Blue Creek expansion protect cash flow, while new high-vol supply depresses Alpha…
Sezzle fell 20% after Q2 despite a revenue and EPS beat and higher guidance, as marketing spending and seasonality drove a sequential…
CAAP reported decent second-quarter earnings and its first dividend, while Brazil rose on an election poll and USMCA trade developments…
Eton Pharmaceuticals licensed rare-disease medicines, raised revenue guidance twice and climbed more than fourfold from its February 2026…
TG Therapeutics' Briumvi growth and subcutaneous formulation progress have fueled takeover rumors, with Biogen, Incyte and Sanofi cited as…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.